Infectious diseases: fortieth and final annual review of significant publications.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000453:epidemiology; D004403:Dysentery / Q000453:epidemiology; D004660:Encephalitis / Q000453:epidemiology; D004756:Enterobacteriaceae Infections / Q000453:epidemiology; D004769:Enterovirus Infections / Q000453:epidemiology; D006069:Gonorrhea / Q000453:epidemiology; D006506:Hepatitis A / Q000453:epidemiology; D006566:Herpesviridae Infections / Q000453:epidemiology; D006801:Humans; D007251:Influenza, Human / Q000453:epidemiology; D008288:Malaria / Q000453:epidemiology; D009164:Mycobacterium Infections / Q000453:epidemiology; D009175:Mycoplasma Infections / Q000453:epidemiology; D009858:Oncogenic Viruses; D009976:Orthomyxoviridae Infections / Q000453:epidemiology; D011008:Pneumococcal Infections / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000453:epidemiology; D012409:Rubella / Q000453:epidemiology; D013290:Streptococcal Infections / Q000453:epidemiology; D014777:Virus Diseases / Q000453:epidemiology*
D000900:Anti-Bacterial Agents